NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I don’t agree. And biotechs do hit that market cap with asset values worth more, and anticipation of things to happen. Granted that market conditions can be such that much better valuations could be challenging for a while, though that is not necessarily my view. I do recognize that companies can continue broadly undervalued, but $2-4 is certainly achievable pre-approval and even more, it really depends on unknowables right now, so your prediction is not solid. I am not claiming I know, but I do know what is possible and I do sense that some NEED this to go lower and they need to establish a baseline of pessimistic views to do that.